Tallahassee, FL 12/1/11 (StreetBeat) --Nature's Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk) announced that it has executed the closing document and consummated the purchase of the weight loss formula.
According to government data, 66% of the 229.5 million American adults are now overweight, or 151 million people, of which 71 million are considered obese. These are the people who are in greater and more immediate danger of developing obesity-related health complications such as heart attacks or diabetes. The larger group of 158 million overweight Americans constitutes the share, for whom their overweight condition is not life threatening; i.e. they're concerned with cosmetic weight loss to help them look and feel better.
According to surveys of American dieting habits performed by the Calorie Control Council, there are 72 million Americans on some kind of diet program. Male – 40% (28.8 million) Female – 60% (43.2 million). Market data projects the total 2010 U.S. weight loss market at $68.7 billion . The recession and the possibility of a double dip recession, has, and may, continue to hurt discretionary income and enrollments in structured programs. Dieters will continue to shift to less costly retail and do-it-yourself options such as: meal replacements, OTC diet pills, mail order plans, diet websites, and fad diet books.
Robert deZanger, CEO of Natures Bioceuticals, reiterates, "We are pleased to add the weight loss formula to our line of natural medicines. This very special formula will provide people a proven product that will help them lose weight. Our formula contains a proprietary blend of natural herbs that has caused weight loss in all people who have tried it. The formula simply curbs the appetite and speeds up the metabolism of those who take it. There is no jittery feeling associated with the product. People who take the formula notice no change in the way they feel. They simply are not as hungry and lose weight. There are many weight loss products on the market and the competition is fierce. We anticipate competition from at least one and probably several new prescription diet drugs that are likely to be approved for sale in the U.S. However, there is an ever increasing trend of people seeking natural remedies as the facts about the dangers of many prescription drugs come to light. We feel that we have a special product that will be well received and take off as people realize that it works. Further, management feels that the ban by the FDA of products with Ephedra and the negative press on other products containing similar 'stimulants' have left many people desperate to lose weight searching for an alternative. Obviously this is a huge market and capturing a small percentage can generate substantial profits for the company."
StreetBeat Disclaimer
No comments:
Post a Comment